Danske Bank A S Takes Position in Intuitive Surgical, Inc. $ISRG

Danske Bank A S bought a new position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) during the 3rd quarter, Holdings Channel.com reports. The firm bought 202,378 shares of the medical equipment provider’s stock, valued at approximately $90,510,000.

Other institutional investors also recently modified their holdings of the company. Mizuho Markets Cayman LP acquired a new position in Intuitive Surgical in the third quarter valued at $165,000. Second Line Capital LLC grew its holdings in Intuitive Surgical by 12.7% during the 3rd quarter. Second Line Capital LLC now owns 586 shares of the medical equipment provider’s stock worth $262,000 after acquiring an additional 66 shares during the period. Silvant Capital Management LLC raised its position in shares of Intuitive Surgical by 4.1% in the 3rd quarter. Silvant Capital Management LLC now owns 90,368 shares of the medical equipment provider’s stock worth $40,415,000 after acquiring an additional 3,539 shares in the last quarter. Peloton Wealth Strategists lifted its stake in shares of Intuitive Surgical by 20.2% in the 3rd quarter. Peloton Wealth Strategists now owns 1,196 shares of the medical equipment provider’s stock valued at $535,000 after purchasing an additional 201 shares during the period. Finally, Morningstar Investment Management LLC bought a new stake in shares of Intuitive Surgical during the 3rd quarter valued at about $13,152,000. 83.64% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

Several research firms recently commented on ISRG. Wall Street Zen cut Intuitive Surgical from a “buy” rating to a “hold” rating in a research note on Saturday, February 7th. Zacks Research upgraded Intuitive Surgical from a “hold” rating to a “strong-buy” rating in a report on Thursday, February 19th. The Goldman Sachs Group reaffirmed a “buy” rating and set a $714.00 price objective on shares of Intuitive Surgical in a research report on Friday, January 9th. Royal Bank Of Canada lifted their price objective on shares of Intuitive Surgical from $625.00 to $650.00 and gave the company an “outperform” rating in a research note on Wednesday, December 17th. Finally, HSBC increased their target price on shares of Intuitive Surgical from $644.00 to $653.00 and gave the stock a “buy” rating in a research note on Monday, January 26th. Two research analysts have rated the stock with a Strong Buy rating, sixteen have given a Buy rating, six have given a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat, Intuitive Surgical currently has an average rating of “Moderate Buy” and a consensus target price of $614.95.

Intuitive Surgical Stock Performance

Shares of NASDAQ:ISRG opened at $482.76 on Wednesday. Intuitive Surgical, Inc. has a 52-week low of $425.00 and a 52-week high of $603.88. The business’s 50 day simple moving average is $509.40 and its two-hundred day simple moving average is $513.09. The firm has a market cap of $171.44 billion, a P/E ratio of 61.19, a PEG ratio of 3.73 and a beta of 1.66.

Intuitive Surgical (NASDAQ:ISRG) last issued its earnings results on Thursday, January 22nd. The medical equipment provider reported $2.53 earnings per share for the quarter, topping analysts’ consensus estimates of $2.27 by $0.26. The company had revenue of $2.87 billion for the quarter, compared to analyst estimates of $2.72 billion. Intuitive Surgical had a return on equity of 15.06% and a net margin of 28.38%.Intuitive Surgical’s revenue for the quarter was up 18.8% on a year-over-year basis. During the same period in the prior year, the firm earned $2.21 earnings per share. On average, equities analysts forecast that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Intuitive Surgical News Roundup

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: UBS lowered its price target on ISRG from $570 to $550 and kept a “neutral” rating; the firm still implies roughly mid‑teens upside from current levels, which supports the idea there is some analyst‑driven upside remaining for the stock. UBS lowers ISRG price target (Benzinga)
• Neutral Sentiment: Senseonics reports strong one‑year real‑world data for its Eversense 365 CGM, reinforcing demand trends in diabetes technologies that broadly support medtech device adoption but do not directly impact ISRG. Senseonics Reports Strong One-Year Real-World Data for Eversense 365
• Neutral Sentiment: ResMed expands mask and device sales while showing strong liquidity — a reminder that respiratory and home‑care device markets remain active; this is a sector data point rather than a direct ISRG catalyst. Is Resmed Stock the Right Pick for Your Portfolio Now?
• Neutral Sentiment: KORU Medical gained EU MDR certification for its Freedom60 infusion pump, illustrating regulatory progress in adjacent medtech niches and potential for broader adoption of home/portable devices. KORU Medical Secures EU MDR Certification for Freedom60 Infusion Pump
• Neutral Sentiment: Industry coverage pieces on companies like DexCom, Bio‑Techne and Cencora highlight mixed sector dynamics—growth opportunities but margin/competition pressures—that provide context for how investors may rotate within medtech/healthcare names. Here’s Why You Should Hold DexCom Stock Should You Continue to Hold Bio-Techne Stock? Here’s Why You Should Hold Cencora Stock
• Neutral Sentiment: General investing commentary (e.g., lists of long‑term compounders) offers high‑level perspectives but is not a direct ISRG catalyst. 2 Stocks That Could Create Lasting Generational Wealth
• Negative Sentiment: Security incident: a report says Intuitive Surgical was the second major medtech company hit with a cybersecurity breach in one week — this raises potential near‑term risks around product security, remediation costs, regulatory scrutiny and reputational damage. Investors should monitor company disclosures and any operational impacts. Intuitive Surgical 2nd Major Medtech Company Hit with Cybersecurity Breach in 1 Week

Insider Transactions at Intuitive Surgical

In other news, VP Fredrik Widman sold 133 shares of the stock in a transaction that occurred on Wednesday, February 11th. The stock was sold at an average price of $494.96, for a total value of $65,829.68. Following the completion of the sale, the vice president directly owned 660 shares of the company’s stock, valued at $326,673.60. This represents a 16.77% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director Gary S. Guthart sold 24,500 shares of Intuitive Surgical stock in a transaction that occurred on Tuesday, January 27th. The shares were sold at an average price of $530.10, for a total value of $12,987,450.00. Following the transaction, the director directly owned 3,694 shares in the company, valued at approximately $1,958,189.40. The trade was a 86.90% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last three months, insiders sold 32,943 shares of company stock valued at $17,279,568. Corporate insiders own 0.70% of the company’s stock.

Intuitive Surgical Company Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.